TechNation Radio Podcast

On this week’s Tech Nation, Moira speaks with former UC Irvine professor, Dr. Hans Keirstead, the chairman and CEO of Aivita Biomedical. They’re talking about adult stem cells, in your body right now, and work in treating spinal cord injury, and in ovarian cancer, melanoma, the skin cancer, glioblastoma … and even in a vaccine for COVID-19, this one designed to be affordable for everyone, everywhere.

On this week’s Tech Nation, Dr. Jonathan Javitt from NeuroRX Pharma talks about a scientific discovery which lingered for nearly two decades in some 70 boxes in deep storage – it’s now being tested as a treatment for COVID-19. Then Rick Carreon, the CEO of ImpediMed, tells us about a technology developed in the 1990’s for research purposes. Today it’s approved for the early detection of lymphedema following breast cancer – and early intervention can stop its progression.

On this week’s Tech Nation, Moira speaks with Dr. Greg Frost, the CEO of Exuma Biotech. He explains how gene therapy for cancer is currently a 6 to 8 week proposition, and requires the patient to undergo chemotherapy. Exuma’s aim is to reduce the time to 4 hours and eliminate the chemotherapy …Then Dr. Chris Smith with Brandon Capital Partners and a board member of Ena Respiratory talks about updates us on Ena-51 – a spray to reduce the presence of COVID in the nasal passageway.

On this week’s Tech Nation, Moira speaks with Professor Antonio Damasio, the Director of the University of Southern California’s Brain and Creativity Institute. He talks about his book is “Feeling & Knowing: Making Minds Conscious”. Then a developing treatment for ALS – often referred to as Lou Gehrig’s disease. Rob Etherington and Robert Glanzman from Clene Nanomedicine talk about using trillions of gold nanocrystals now being tested in advanced clinical trials.

On this week’s Tech Nation, Moira speaks with the last Tech Nation interview of Glen de Vries, who flew into space with William Shatner aboard Blue Origin. A short month after this flight, Glen passed away in a plane crash. We talk about how his earthbound work help us all, and his book: “The Patient Equation”. Then why the new FDA-approved treatment for yeast infections in women is … different. And Dr Marco Taglietti, the President and CEO of Scynexis, describes their unprecedented FDA-approved treatment for Yeast Infections in Women.

On this week’s Tech Nation, Moira speaks with Harvard economics professors Edward Glaeser and David Cutler about “Survival of the City … Living and Thriving in an Age of Isolation.” Then Dr. Alex Pang’s advice about our work life from his 2016 book, “Rest … Why You Get More Done When You Work Less” is even more relevant now. And Tech Nation Health Chief Correspondent Dr Daniel Kraft talks to us about something unprecedented … our teeth!

On this week’s Tech Nation, Moira speaks with Dr. Sidarta Ribeiro, Deputy Director of the Brain Institute at the Unversidade Federal do Rio Grande do Norte in Brazil. His book is “The Oracle of Night … The History and Science of Dreams”. Then, a potential new treatment for a side effect of chemotherapy: Hand-Foot Skin Reaction and Hand-Foot Syndrome. Dr. Michael McCullar, the CEO of OnQuality Pharmaceuticals talks about their new drug candidate which has just finished Phase II clinical trials.

On this week’s Tech Nation, Moira speaks with Emory Professor Dr. Cassandra Quave talks about “The Plant Hunter: A Scientist’s Quest for Nature’s Next Medicines”. And David McNally, President and CEO of Titan Medical. Advances in Robot-assisted surgery – from a long scar to several tiny incisions, and now, perhaps, just one.

On this week’s Tech Nation, Moira speaks with Dr. Bessel van der Kolk about his perpetually best-selling book: “The Body Keeps the Score: Brain, Mind and Body in the Healing of Trauma.” We’ll also hear Dr. Gunn’s 2005 interview with Elizabeth Holmes, the founder and CEO of the now-defunct Theranos, who is currently standing trial for fraud.

On this week’s Tech Nation, Moira speaks with Columbia University professor Eric Johnson about “The Elements of Choice: Why the Way We Decide Matters”. Then insight into rare genetic diseases with Dr. Dietrich Stephan, CEO of NeuBase Therapeutics. He talks us through rare genetic diseases, as well as NeuBase’s approach. And Tech Nation Health Chief Correspondent Dr. Daniel Kraft talks about the challenges of Telehealth.